Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001546927-16-000454
Filing Date
2016-03-14
Accepted
2016-03-14 08:37:15
Documents
1
Period of Report
2016-03-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT opaleyeimmyform4filed.html 4  
1 OWNERSHIP DOCUMENT opaleyeimmyform4filed.xml 4 4498
  Complete submission text file 0001546927-16-000454.txt   6293
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110
Business Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110 617-904-9195
Opaleye Management Inc. (Reporting) CIK: 0001595855 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 161502536